Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19.

Cite

CITATION STYLE

APA

Li, Y., Wang, Z., Lian, N., Wang, Y., Zheng, W., & Xie, K. (2021, October 22). Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19. Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2021.671215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free